CN1662647A - 植物胸苷激酶及其用途 - Google Patents

植物胸苷激酶及其用途 Download PDF

Info

Publication number
CN1662647A
CN1662647A CN038138425A CN03813842A CN1662647A CN 1662647 A CN1662647 A CN 1662647A CN 038138425 A CN038138425 A CN 038138425A CN 03813842 A CN03813842 A CN 03813842A CN 1662647 A CN1662647 A CN 1662647A
Authority
CN
China
Prior art keywords
plant
thymidine kinase
seq
thymidine
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN038138425A
Other languages
English (en)
Chinese (zh)
Inventor
沃尔夫冈·克内希特
比吉特·芒克－彼得森
尤雷·皮斯克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1662647A publication Critical patent/CN1662647A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01076—Deoxyadenosine kinase (2.7.1.76)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
CN038138425A 2002-05-23 2003-05-21 植物胸苷激酶及其用途 Pending CN1662647A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200200794 2002-05-23
DKPA200200794 2002-05-23
DKPA200300178 2003-02-07
DKPA200300178 2003-02-07

Publications (1)

Publication Number Publication Date
CN1662647A true CN1662647A (zh) 2005-08-31

Family

ID=29585606

Family Applications (1)

Application Number Title Priority Date Filing Date
CN038138425A Pending CN1662647A (zh) 2002-05-23 2003-05-21 植物胸苷激酶及其用途

Country Status (15)

Country Link
US (1) US7928206B2 (cg-RX-API-DMAC7.html)
EP (1) EP1509600B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006504403A (cg-RX-API-DMAC7.html)
CN (1) CN1662647A (cg-RX-API-DMAC7.html)
AT (1) ATE419337T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003229543B2 (cg-RX-API-DMAC7.html)
CA (1) CA2485182A1 (cg-RX-API-DMAC7.html)
DE (1) DE60325587D1 (cg-RX-API-DMAC7.html)
DK (1) DK1509600T3 (cg-RX-API-DMAC7.html)
ES (1) ES2320434T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA04011572A (cg-RX-API-DMAC7.html)
NZ (1) NZ536623A (cg-RX-API-DMAC7.html)
PT (1) PT1509600E (cg-RX-API-DMAC7.html)
RU (1) RU2339695C2 (cg-RX-API-DMAC7.html)
SI (1) SI1509600T1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114107339A (zh) * 2021-12-09 2022-03-01 菏泽学院 泡桐丛枝植原体胸苷激酶基因引物、基因、融合蛋白、多克隆抗体及其应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112007002378T5 (de) 2006-10-24 2009-09-03 Bradley Fixtures Corp., Menomonee Falls Kapazitive Messung für Waschraum-Armaturen
JP5211303B2 (ja) * 2007-10-25 2013-06-12 独立行政法人産業技術総合研究所 蛋白質の製造方法
CN117016549B (zh) * 2023-03-13 2024-02-27 山东蓬勃生物科技有限公司 核苷类化合物及其组合物在促进植物生长中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877010A (en) * 1994-05-02 1999-03-02 University Of Washington Thymidine kinase mutants
US6197743B1 (en) * 1996-07-26 2001-03-06 The Trustees Of Boston University Compositions and methods for the treatment of viral disorders
EP2386630A1 (en) 1997-10-14 2011-11-16 Darwin Molecular Corporation Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
WO1999067372A1 (en) 1998-06-22 1999-12-29 The Board Of Trustees Of The University Of Arkansas Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
GB0008966D0 (en) * 2000-04-13 2000-05-31 Imp College Innovations Ltd Vectors for gene therapy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114107339A (zh) * 2021-12-09 2022-03-01 菏泽学院 泡桐丛枝植原体胸苷激酶基因引物、基因、融合蛋白、多克隆抗体及其应用
CN114107339B (zh) * 2021-12-09 2024-06-07 菏泽学院 泡桐丛枝植原体胸苷激酶基因引物、基因、融合蛋白、多克隆抗体及其应用

Also Published As

Publication number Publication date
RU2004133390A (ru) 2005-08-10
US20060035850A1 (en) 2006-02-16
RU2339695C2 (ru) 2008-11-27
SI1509600T1 (sl) 2009-06-30
PT1509600E (pt) 2009-03-26
EP1509600A1 (en) 2005-03-02
CA2485182A1 (en) 2003-12-04
AU2003229543B2 (en) 2008-03-20
JP2006504403A (ja) 2006-02-09
DE60325587D1 (de) 2009-02-12
NZ536623A (en) 2006-05-26
ES2320434T3 (es) 2009-05-22
ATE419337T1 (de) 2009-01-15
EP1509600B1 (en) 2008-12-31
MXPA04011572A (es) 2005-07-05
AU2003229543A1 (en) 2003-12-12
DK1509600T3 (da) 2009-04-27
US7928206B2 (en) 2011-04-19

Similar Documents

Publication Publication Date Title
CN1197966C (zh) 肿瘤坏死因子受体相关因子的调节剂、及其制备和用途
CN1806042A (zh) 具有反馈抗性的甲羟戊酸激酶
CN1313773A (zh) 来自端粒酶的抗原性肽
CN1229499C (zh) 磷酸二酯酶8a
CN101080490A (zh) 改进的甲羟戊酸激酶
CN1151186A (zh) 胸苷激酶突变体
CN1429268A (zh) 新型脱氧核苷激酶多底物变体
CN1091139A (zh) 蛋白质酪氨酸磷酸酶的ptp-d亚家族
CN1109260A (zh) 转导醛脱氢酶-1基因的反转录病毒载体及其应用
CN1218512A (zh) 用于人类肿瘤基因治疗的重组腺病毒载体
CN1303435A (zh) Tao蛋白激酶及其使用方法
CN1662647A (zh) 植物胸苷激酶及其用途
CN1286973C (zh) 一种组蛋白甲基转移酶及其制备方法
CN1259165A (zh) 胞内发炎、细胞死亡和细胞存活通道的调节剂
WO2003100045A1 (en) Plant thymidine kinases and their use
CN1239713C (zh) S140g突变型kcnq1蛋白及其在筛选离子通道抑制剂和促进剂中的应用
CN1526017A (zh) 与利什曼原虫属寄生虫毒性相关的基因
CN1384878A (zh) Iren蛋白,其制备和应用
CN1201009C (zh) 组氨酸蛋白磷酸酶
CN1160370C (zh) 新的人细胞周期控制相关蛋白及其编码序列
CN1436239A (zh) 新酶基因及其表达产物
CN1212398C (zh) 新型ifn受体1结合蛋白质,编码它们的dna,以及调节细胞对干扰素的反应的方法
CN1255186C (zh) 人端粒酶反转录酶样组分的基因突变体的新用途
CN1798837A (zh) 修饰的硫氧还蛋白
CN1243017C (zh) 肿瘤抑制基因及其编码蛋白和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20050831

C20 Patent right or utility model deemed to be abandoned or is abandoned